H1N1 Vaccine Piles Up As Hysteria About Epidemic Fades

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Millions of people in the US contracted the H1N1 flu virus aka swine flu. Almost none of those people died.

The WHO and several medical and health organizations in the US believed that H1N1 would be the new super virus which would cause overflowing emergency rooms, worker shortages at companies where people might be home or in a hospital for days, and hundreds of thousands if not millions of deaths around the world.

According to The Wall Street Journal, “The government has so far taken delivery of about 111 million doses of vaccine. It has purchased the equivalent of more than 250 million doses.” The additional doses will probably never be used.

Experts in the field of mass psychology will probably look at the panic about the swine flu and the subsequent mildness of the disease as a sign the health organizations overreacted. That, in turn, will cause most people to ignore warnings when the next major mutation of flu viruses begins to spread. And, one year, perhaps in the not very distant future, a really virulent flu will begin to sicken people and kill them in great numbers because false alarms will have blunted potential hysteria.

Douglas A. McIntyre

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618